News
March 7, 2008 – CircuLite has advanced its Synergy Pocket Circulatory Assist Device clinical program into a 20-patient trial, after completion of a first-in-man pilot study of Synergy in four patients, as the company seeks CE Mark approval in the European Union for long-term implantation of Synergy in heart failure patients.
March 06, 2008
News
March 7, 2008 - Siemens Healthcare launched the DCA Vantage Analyzer, a point-of-care (POC) diabetes patient management ...
March 06, 2008
Technology
Siemens Healthcare now has available the DCA Vantage Analyzer, a point-of-care (POC) diabetes patient management ...
March 06, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
March 7, 2008 – KLAS recently named Toshiba’s Aquilion 64, Xario and Vantage 1.5T MR “Best in KLAS” in its Top 20 Year ...
March 06, 2008
Technology
GE's SnapShot Pulse offers improved dose reduction results for both diagnostic cardiac and neuro perfusion CT exams and ...
March 06, 2008News
March 5, 2008 - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency ...
March 05, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
March 6, 2008 - The third annual Medical Device Regulatory, Reimbursement and Compliance Congress (Device Congress) to ...
March 05, 2008News
March 6, 2008 - Axellis Ltd., the UK- and US-based medical technology company, has completed acquisitions of three ...
March 05, 2008News
March 5, 2008 - Edwards Lifesciences Corp. reported that the first three human implants of the next-generation Edwards transcatheter aortic heart valve were performed at St. Paul's Hospital in Vancouver, British Columbia, marking the progression of minimally-invasive valve therapy.
March 04, 2008Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
For patient monitoring systems not integrated with PiCCO-Technology, Pulsion Medical Systems offers the PiCCO parameters ...
March 04, 2008News
March 4, 2008 – MEDRAD sales revenues grew to $525 million in 2007, an increase of 10 percent over the previous year, which is expected to grow further should the merger with Possis be completed.
March 04, 2008News
February 5, 2008 - Doctors completed the first implant of Boston Scientific’s COGNIS cardiac resynchronization therapy defibrillator (CRT-D), which reportedly represents an entirely new platform to treat heart failure.
March 04, 2008Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
Edwards Lifesciences provides The Vigilance II monitor, which is designed to gives users the ability to present complex ...
March 04, 2008News
March 3, 2008 - Boston Scientific Corp. received CE Mark approval of its ACUITY Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, marking the company�s seventh U.S. or European regulatory approval in the past nine weeks.
March 04, 2008News
March 4, 2008 - By using a dual-source technique on a single computed tomography (CT) system, a research team at the ...
March 03, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now